Rochester Medical Corporation 

(Public, NASDAQ:ROCM)   Watch this stock   
Find more results for ROCM
Jan 26, 2010
Q1 2010 Earnings Release - 12:00PM EST - Add to calendar
Nov 5, 2009
Q4 2009 Earnings Conference Call - Webcast
Nov 5, 2009
Q4 2009 Earnings Release
More events from AOL Finance »    

Key stats and ratios

Q2 (Jun '09) 2008
Net profit margin -0.88% 2.15%
Operating margin -1.82% -1.40%
EBITD margin - 3.81%
Return on average assets -0.42% 0.99%
Return on average equity -0.47% 1.15%
Employees 271 -

Address

One Rochester Medical Drive
Stewartville, MN 55976
United States - Map
+1-507-5339600 (Phone)
+1-507-5334232 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance
Annual Report (PDF) - AnnualReports.com

Rochester Medical Corporation discussed on blogs

Rochester Medical Corporation discussions

  View all discussions »

Description

Rochester Medical Corporation develops, manufactures and markets a line of polyvinyl chloride (PVC)-free and latex-free urinary continence and urine drainage care products for the extended care and acute care markets. The Company’s extended care products include a line of male external catheters for managing male urinary incontinence and a line of intermittent catheters for managing both male and female urinary retention. Along with its line of silicone male external catheters, the Company also sells a line of latex male external catheters in the United Kingdom. The Company’s extended care products also include the FemSoft Insert, a soft, liquid-filled, conformable urethral insert for managing female stress urinary incontinence in adult females. Its cute care products include a line of standard Foley catheters and its RELEASE-NF Catheter, an antibacterial Foley catheter that reduces the incidence of hospital acquired urinary tract infection (UTI).

Officers and directors

Anthony J. Conway
Chairman of the Board, President, Chief Executive Officer
Age: 64
Bio & Compensation - Reuters
David A. Jonas
Chief Financial Officer, Treasurer, Secretary, Director
Age: 44
Bio & Compensation - Reuters
James M. Carper
Vice President - Marketing
Age: 57
Bio & Compensation - Reuters
Philip J. Conway
Vice President - Production Technologies
Age: 52
Bio & Compensation - Reuters
Martyn R. Sholtis
Corporate Vice President
Age: 49
Bio & Compensation - Reuters
Robert M. Anglin
Vice President - Quality & Regulatory
Age: 41
Bio & Compensation - Reuters
Darnell L. Boehm
Director
Age: 60
Bio & Compensation - Reuters
Roger W. Schnobrich
Director
Age: 78
Bio & Compensation - Reuters
Benson F. Smith
Director
Age: 61
Bio & Compensation - Reuters